切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2017, Vol. 10 ›› Issue (03) : 368 -372. doi: 10.3877/cma.j.issn.1674-6902.2017.03.036

所属专题: 文献

综述

慢性阻塞性肺疾病与阻塞性睡眠呼吸暂停综合征-重叠综合征
李明娴1,(), 白晓月1, 刑利平1   
  1. 1. 130000 长春,吉林大学第一医院呼吸内科
  • 收稿日期:2017-03-01 出版日期:2017-06-20
  • 通信作者: 李明娴

Chronic obstructive pulmonary disease and obstructive sleep apnea syndrome-overlap syndrome

Mingxian Li1(), Xiaoyue Bai1, Liping Xin1   

  • Received:2017-03-01 Published:2017-06-20
  • Corresponding author: Mingxian Li
引用本文:

李明娴, 白晓月, 刑利平. 慢性阻塞性肺疾病与阻塞性睡眠呼吸暂停综合征-重叠综合征[J]. 中华肺部疾病杂志(电子版), 2017, 10(03): 368-372.

Mingxian Li, Xiaoyue Bai, Liping Xin. Chronic obstructive pulmonary disease and obstructive sleep apnea syndrome-overlap syndrome[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2017, 10(03): 368-372.

1
World Health Organization. Chronic obstructive pulmonary disease. Accessed August 3, 2016.

URL    
2
Tan WC, Sin DD, Bourbeau J, et al. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study[J]. Thorax, 2015, 70(9): 822-829.
3
Byrne AL, Marais BJ, Mitnick CD, et al. Tuberculosis and chronic respiratory disease: a systematic review[J]. Int J Infect Dis, 2015, 32: 138-146.
4
Langer D, Ciavaglia CE, Neder JA, et al. Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment[J]. Expert Rev Respir Med, 201, 8(6): 731-749.
5
Cho MH, Castaldi PJ, Hersh CP, et al. A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes[J]. Am J Respir Crit Care Med, 2015, 192(5): 559-569.
6
Hogg JC, McDonough JE, Suzuki M. Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging[J]. Chest, 2013, 143(5): 1436-1443.
7
Lynch TJ, Engelhardt JF. Progenitor cells in proximal airway epithelial development and regeneration[J]. J Cell Biochem, 2014, 115(10): 1637-1645.
8
Dijkstra AE, Boezen HM, van den Berge M, et al. Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD[J]. Eur Respir J, 2015, 45(1): 60-75.
9
Cebron Lipovec N, Beijers RJ, van den Borst B, et al. The Prevalence of metabolic syndrome in chronic obstructive pulmonary disease: A systematic review[J]. COPD, 2016, 13(3): 399-406.
10
Oelsner EC, Carr JJ, Enright PL, et al. Percent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study [J]. Thorax, 2016, 71(7): 624-632.
11
Houben-Wilke S, Jorres RA, Bals R, et al. Peripheral artery disease and its clinical relevance in patients with COPD in the COSYCONET Study [J]. Am J Respir Crit Care Med, 2017, 195(2): 189-197.
12
MacDonald MI, Shafuddin E, King PT, et al. Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease[J]. Lancet Respir Med, 2016, 4(2): 138-148.
13
Testelmans D, Tamisier R, Barone-Rochette G, et al. Profile of circulating cytokines: impact of OSA, obesity and acute cardiovascular events[J]. Cytokine, 2013, 62(2): 210-216.
14
Lim DC, Pack AI. Obstructive Sleep Apnea: Update and Future[J]. Annu Rev Med, 2017, 68: 99-112.
15
Chi L, Comyn FL, Keenan BT, et al. Heritability of craniofacial structures in normal subjects and patients with sleep apnea [J]. Sleep, 2014, 37(10): 1689-1698.
16
Eckert DJ, White DP, Jordan AS, et al. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets[J]. Am J Respir Crit Care Med, 2013, 188(8): 996-1004.
17
Prabhakar NR, Peng YJ, Kumar GK, et al. Peripheral chemoreception and arterial pressure responses to intermittent hypoxia[J]. Compr Physiol, 2015, 5(2): 561-577.
18
Ayas NT, Hirsch AA, Laher I, et al. New frontiers in obstructive sleep apnea[J]. Clin Sci, 2014, 127(4): 209-216.
19
Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, et al. Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort[J]. Am J Respir Crit Care Med, 2013, 187(1): 99-105.
20
Lim DC, Brady DC, Soans R, et al. Different cyclical intermittent hypoxia severities have different effects on hippocampal microvasculature[J]. J Appl Physiol (1985), 2016, 121(1): 78-88.
21
Emamian F, Khazaie H, Tahmasian M, et al. The Association between obstructive sleep apnea and alzheimer′s disease: A Meta-analysis perspective [J]. Front Aging Neurosci, 2016, 8: 78.
22
Pinto JA, Ribeiro DK, Cavallini AF, et al. Comorbidities associated with obstructive sleep apnea: a retrospective study[J]. Int Arch Otorhinolaryngol, 2016, 20(2): 145-150.
23
Opperer M, Cozowicz C, Bugada D, et al. Does obstructive sleep apnea influence perioperative outcome A qualitative systematic review for the society of anesthesia and sleep medicine task force on preoperative preparation of patients with sleep-disordered breathing[J]. Anesth Analg, 2016, 122(5): 1321-1334.
24
Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults[J]. Am J Epidemiol, 2013,177(9): 1006-1014.
25
Flenley DC. Sleep in chronic obstructive lung disease[J]. Clin Chest Med, 1985, 6(4): 651-661.
26
Tang SF, Wang X, Zhang Y, et al. Analysis of high alert medication knowledge of medical staff in Tianjin: A convenient sampling survey in China[J]. J Huazhong Univ Sci Technolog Med Sci, 2015, 35(2): 176-182.
27
Greenberg-Dotan S, Reuveni H, Tal A, et al. Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea[J]. Sleep and Breathing, 2014, 18(1): 69-75.
28
Price D, Small M, Milligan G, et al. Impact of night-time symptoms in COPD: a real-world study in five European countries[J]. Int J Chron Obstruct Pulmon Dis, 2013, 8: 595-603.
29
Soler X, Gaio E, Powell FL, et al. High prevalence of obstructive sleep apnea in patients with moderate to severe COPD[J]. Ann Am Thorac Soc, 2015, 12(8): 1219-1225.
30
Krachman SL, Tiwari R, Vega ME, et al. Effect of emphysema severity on the apnea-hypopnea index in smokers with obstructive sleep apnea[J]. Ann Am Thorac Soc, 2016, 13(7): 1129-1135.
31
Lacedonia D, Salerno FG, Sabato R, et al. Airway cell patterns in patients suffering from COPD and OSAS (Overlap Syndrome)[J]. Respir Med, 2011, 105(2): 303-309.
32
Bikov A, Hull JH, Kunos L. Exhaled breath analysis, a simple tool to study the pathophysiology of obstructive sleep apnoea[J]. Sleep Med Rev, 2016, 27: 1-8.
33
Philippe C, Boussadia Y, Pruliere-Escabasse V, et al. Airway cell involvement in intermittent hypoxia-induced airway inflammation[J]. Sleep Breath, 2015, 19(1): 297-306.
34
Laveneziana P, Palange P, ERS Research seminar faculty. Physical activity, nutritional status and systemic inflammation in COPD[J]. Eur Respir J, 2012, 40(3): 522-529.
35
Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation[J]. Am J Respir Crit Care Med, 2013, 188(8): e13-e64.
36
Aihara K, Oga T, Chihara Y, et al. Analysis of systemic and airway inflammation in obstructive sleep apnea [J]. Sleep Breath, 2013, 17(2): 597-604.
37
Wang Y, Hu K, Liu K, et al. Obstructive sleep apnea exacerbates airway inflammation in patients with chronic obstructive pulmonary disease[J]. Sleep Med, 2015, 16(9): 1123-1130.
38
Basoglu OK, Gunduz C, Tasbakan MS. Prevalence of overlap syndrome in chronic obstructive pulmonary disease patients without sleep apnea symptoms[J]. Clin Respir J, 2016. doi: 10.1111/crj.12493.
39
McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnoea-the overlap syndrome[J]. J Thorac Dis, 2016, 8(2): 236-242.
40
He BT, Lu G, Xiao SC, et al. Coexistence of OSA may compensate for sleep related reduction in neural respiratory drive in patients with COPD[J].Thorax, 2017, 72(3): 256-262.
41
Huang H, Yao L. Analysis of airway resistance and hypoxemia in overlap syndrome[J]. Saudi Med J, 2016, 37(7): 758-761.
42
Sharma B, Neilan TG, Kwong RY, et al. Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea [J]. COPD, 2013, 10(1): 4-10.
43
Neilan TG, Bakker JP, Sharma B, et al. T1 measurements for detection of expansion of the myocardial extracellular volume in chronic obstructive pulmonary disease[J]. Can J Cardiol, 2014, 30(12): 1668-1675.
44
Matsumoto T, Murase K, Tachikawa R, et al. Microalbuminuria in patients with obstructive sleep apnea-chronic obstructive pulmonary disease overlap syndrome[J]. Ann Am Thorac Soc, 2016, 13(6): 917-925.
45
Steveling EH, Clarenbach CF, Miedinger D, et al. Predictors of the overlap syndrome and its association with comorbidities in patients with chronic obstructive pulmonary disease[J]. Respiration, 2014, 88(6): 451-457.
46
Khatri SB, Ioachimescu OC. The intersection of obstructive lung disease and sleep apnea[J]. Cleve Clin J Med, 2016, 83(2): 127-140.
47
Soler X, Diaz-Piedra C, Ries AL. Pulmonary rehabilitation improves sleep quality in chronic lung disease[J]. COPD, 2013, 10(2): 156-163.
48
Donovan LM, Boeder S, Malhotra A, et al. New developments in the use of positive airway pressure for obstructive sleep apnea[J]. J Thorac Dis, 2015, 7(8): 1323-1342.
49
Becker HF, Piper AJ, Flynn WE, et al. Breathing during sleep in patients with nocturnal desaturation[J]. Am J Respir Crit Care Med, 1999, 159(1): 112-118.
50
Machado MC, Vollmer WM, Togeiro SM, et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD[J]. Eur Respir J, 2010, 35(1): 132-137.
51
Stanchina ML, Welicky LM, Donat W, et al. Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome[J]. J Clin Sleep Med, 2013, 9(8): 767-772.
52
Turnbull CD, Bratton DJ, Craig SE, et al. In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP[J]. J Thorac Dis, 2016, 8(2): 276-281.
53
Jaoude P, Kufel T, El-Solh AA. Survival benefit of CPAP favors hypercapnic patients with the overlap syndrome[J]. Lung, 2014, 192(2): 251-258.
54
Camacho M, Zaghi S, Tran D, et al. Inferior turbinate size and CPAP titration based treatment pressures: No association found among patients who have not had nasal surgery[J]. Int J Otolaryngol, 2016, 2016: 5951273.
55
Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial [J]. Lancet Respir Med, 2014, 2(9): 698-705.
56
Carvalho B, Durão S, Elloy C, et al. Increased DNA damage and cell death on exfoliated buccal epithelial cells upon CPAP therapy with oro-nasal interface [J]. Sleep Med, 2017, 29: 92-93.
[1] 马锦芳, 何正光, 郑劲平. 盐酸氨溴索雾化吸入治疗慢性阻塞性肺疾病黏痰症患者的疗效和安全性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 568-574.
[2] 程炜炜, 张青, 张诚实, 冯契靓, 陈荣荣, 赵云峰. 全身免疫炎症指数与慢性阻塞性肺疾病急性加重期病情严重程度相关性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 580-584.
[3] 杨万荣, 任治坤, 时新颍. 沙丁胺醇雾化吸入脾多肽治疗AECOPD的疗效分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 609-612.
[4] 赖乾德, 吕相琴, 蔺洋, 刘媛梅, 赵春艳, 李琦. 肝素结合蛋白对慢性阻塞性肺疾病预后预测分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 613-616.
[5] 王微, 丁霖, 陈茜, 呼延欣, 闫蓓. 综合治疗对慢性阻塞性肺疾病的疗效及转归影响分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 621-624.
[6] 方晓玉, 王婷, 赵珊, 陈锋. HALP指数对AECOPD并发呼吸衰竭患者ICU结局的预测意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 639-641.
[7] 郭少琳, 郭建英, 左秀萍, 高苗. 慢性阻塞性肺疾病康复训练依从性影响因素分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 652-654.
[8] 白若靖, 郭军. 维生素D对肺部疾病临床意义的研究进展[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 659-662.
[9] 孔令梅, 徐晓媛, 马丽颖. 慢性阻塞性肺疾病认知衰弱危险因素及预后分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 407-410.
[10] 袁广琴, 朱珠, 林云霞. 胸腺肽联合无创正压通气救治AECOPD并发Ⅱ型呼吸衰竭患者的临床分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 438-441.
[11] 徐艳, 江秀娟, 王超, 江圆满. 股直肌剪切波弹性成像对COPD并发肌少症的诊断意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 454-457.
[12] 黄映兰, 骆丽萍, 郭慧玲, 袁麟标. 慢性阻塞性肺疾病糖皮质激素治疗反应性的影响因素分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 469-471.
[13] 杨坤, 赵景成, 吴永强. 无创呼吸机在慢性阻塞性肺疾病并发呼吸衰竭救治的临床分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 481-483.
[14] 宋素莉, 贺英华, 陈丽娟. COPD并发吸入性CAP危险因素及病原菌分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 264-267.
[15] 何秀, 敖的, 杨郑, 林小华. 改良呼吸支持策略对慢性阻塞性肺疾病急性加重合并Ⅱ型呼吸衰竭患者的疗效[J]. 中华卫生应急电子杂志, 2024, 10(03): 140-144.
阅读次数
全文


摘要